tyrosine-4-azophenyltrimethylammonium chloride: tool for investigating parameters of immune response [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 170030 |
| MeSH ID | M0043074 |
| Synonym |
|---|
| tyrosine-4-azophenyltrimethylammonium chloride |
| benzenaminium, 4-((5-(2-amino-2-carboxyethyl)-2-hydroxyphenyl)azo)-n,n,n-trimethyl-, chloride, (s)- |
| 38299-26-2 |
| tapt |
| l-tyrosine-4-azophenyltrimethylammonium chloride |
| tyr(tma) |
| l-tyrosine-p-azophenyltrimethylammonium chloride |
| [4-[[5-[(2s)-2-amino-2-carboxyethyl]-2-hydroxyphenyl]diazenyl]phenyl]-trimethylazanium;chloride |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||